Researchers across the biotechnology industry rely on mouse models for advancing our understanding of human biology and disease. These models bring value to the lab with their genetic, physiological, and anatomical similarities to humans, which make them ideal for translational research. For researchers, understanding the pivotal role of mouse models is essential, as the insights gained from these studies often lay the groundwork for human trials and therapeutic developments. With a wide variety of animal models available for researchers, it’s worth taking the time to understand why roughly 95 percent of warm-blooded animals used in research are rats and mice. 

From a manufacturing standpoint, mouse models are essential to the generation of high-quality, specific antibodies like those found in ICL’s ELISA kits. In addition to the House mice (mus musculus), ICL also works with Cotton, Sprague-Dawley, and Wistar rat models. While rats are genetically unique from mice, they play similarly essential roles in the lab, from the initial immunization and antibody production to the validation and quality control of the final product.

One of the most significant advantages of using mouse models is their ability to predict human responses to drugs and therapies. Many of the physiological processes in mice closely resemble those in humans, including immune system function, metabolism, and organ development. As a result, preclinical studies in mice are often predictive of how a drug or therapy might perform in humans, providing a critical steppingstone in the drug development pipeline.

For example, the development of cancer immunotherapies began with mouse models that mimicked human immune responses. These models allowed researchers to understand a tumor’s ability to evade the immune system, giving them the freedom to test the efficacy of new drugs in a controlled environment before moving to human trials. The success of these therapies in mice has translated into groundbreaking treatments for various cancers in humans, saving countless lives.

ELISA kits are instrumental in measuring the levels of specific biomarkers that guide this translational process. Once a biomarker is identified and validated in mouse models, ELISA kits can be adapted or developed to measure the same or analogous biomarkers in human samples. ICL manufactures kits for nearly 30 ELISA targets for mice, ranging from albumin and ferritin to IgE and IgA. These kits allow researchers to assess whether the biological processes or disease mechanisms observed in mice are also relevant in humans and predict and manage potential immunogenic responses in human patients.

While discrepancies exist in drug or therapy performance across species, researchers are increasingly using more sophisticated mouse models that better mimic human conditions. For instance, humanized mice, which are engrafted with human cells or tissues, offer a more accurate representation of human biology. And though they may not be able to replicate the complex conditions in which humans live, these models are particularly useful in fields like infectious disease and oncology, where understanding human-specific interactions is crucial.

For biotech researchers, mouse models are more than just a starting point—they are a bridge to understanding human health and disease. While challenges remain in fully translating findings from mice to humans, the advancements made using these models have already led to significant breakthroughs in medicine. As the field continues to evolve, the refinement of mouse models will undoubtedly enhance their predictive power, making them an even more integral part of the biotech research landscape.

ICL’s ELISA kits for mice targets are rigorously tested, facilitating drug development, disease research, and biomarker discovery. Get in touch with our experts to learn how you can jumpstart translational research and bridge preclinical findings to clinical applications more effectively.